澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Control Bionics Ltd

0.065

+0.0023.17%

成交量：51.72万

成交额：3.41万

市值：3,530.08万

市盈率：-3.32

高：0.066

开：0.066

低：0.065

收：0.063

52周最高：0.095

52周最低：0.032

股本：5.43亿

流通股本：1.14亿

量比：2.37

换手率：0.45%

股息：- -

股息率：- -

每股收益(TTM):-0.020

每股收益(LYR):-0.020

净资产收益率：-122.92%

总资产收益率：-48.20%

市净率：5.59

市盈率(LYR):-3.32

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

Control Bionics与Tobii Dynavox GmbH签署德国市场Neuronode分销协议

Control Bionics Ltd——美国市场准入最后障碍扫清，首批收入瞄准2026年9月

Control Bionics 完成Neurostrip美国FDA注册与设备列名

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/CBL.AU"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CBL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CBL.AU\",,,,,undefined,":{"symbol":"CBL.AU","market":"AU","secType":"STK","nameCN":"Control Bionics Ltd","latestPrice":0.065,"timestamp":1791781920000,"preClose":0.063,"halted":0,"volume":517227,"delay":0,"changeRate":0.03174603174603177,"nameEN":"Control Bionics Ltd","floatShares":114482928,"shares":543088709,"eps":-0.0196,"marketStatus":"未开盘","change":0.002,"latestTime":"10-12 16:12:00 AEDT","open":0.066,"high":0.066,"low":0.065,"amount":34105,"amplitude":0.015873,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.0196,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":0,"beginTime":1791846000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.063,"openAndCloseTimeList":[[1791759600000,1791781200000]],"volumeRatio":2.3749279118897886,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CBL.AU","preClose":0.066,"auctionPrice":0.066,"auctionVolume":5000,"auction":3,"marketStatus":"盘后竞价","timestamp":1791522172652}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CBL.AU\",,,,,undefined,":{"symbol":"CBL.AU","floatShares":114482928,"roa":"-48.20%","roe":"-122.92%","lyrEps":-0.0196,"volumeRatio":2.3749279118897886,"shares":543088709,"dividePrice":0,"high":0.066,"amplitude":0.015873,"preClose":0.063,"low":0.065,"week52Low":0.032,"pbRate":"5.59","psRate":"7.41","week52High":0.095,"institutionHeld":0,"latestPrice":0.065,"eps":-0.0196,"divideRate":0,"volume":517227,"delay":0,"ttmEps":-0.0196,"open":0.066,"prevYearClose":0.061,"prevWeekClose":0.063,"prevMonthClose":0.062,"prevQuarterClose":0.062,"fiveDayClose":0.06,"twentyDayClose":0.061,"sixtyDayClose":0.068,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CBL.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-28","symbol":"CBL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787875200000,"name":null,"time":"","dateTimestamp":1787839200000,"actualEps":null},{"market":"AU","date":"2026-02-26","symbol":"CBL.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1772024400000,"reportTimeType":"","actualEps":null},{"market":"AU","date":"2025-09-01","symbol":"CBL.AU","defaultRemindTime":1756684800000,"type":"split","dateTimestamp":1756648800000,"forFactor":982905,"toFactor":1000000,"ratio":0.9829049999999999},{"date":"2025-07-31","symbol":"CBL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1753920000000,"name":null,"time":"","dateTimestamp":1753884000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CBL.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CBL.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1125786307","title":"Control Bionics与Tobii Dynavox GmbH签署德国市场Neuronode分销协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1125786307","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125786307?lang=zh_cn&edition=fundamental","pubTime":"2026-09-23 06:19","pubTimestamp":1790115548,"startTime":"0","endTime":"0","summary":"Control Bionics宣布，已与Tobii Dynavox GmbH达成一项分销合作协定。根据该协议，Tobii Dynavox GmbH将在德国境内负责Neuronode产品的分销工作。这一战略举措，无疑将为Control Bionics拓展欧洲市场版图注入新的动力。双方的合作，旨在借助Tobii Dynavox在辅助通信领域的深厚积累与渠道优势，让Neuronode技术更广泛地惠及德国用户。此举标志着Control Bionics国际化布局迈出了坚实的一步，其市场影响力有望得到显著提升。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBL.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191648305","title":"Control Bionics Ltd——美国市场准入最后障碍扫清，首批收入瞄准2026年9月","url":"https://stock-news.laohu8.com/highlight/detail?id=1191648305","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191648305?lang=zh_cn&edition=fundamental","pubTime":"2026-08-27 06:02","pubTimestamp":1787781729,"startTime":"0","endTime":"0","summary":"Control Bionics Ltd——通往美国市场的最后一道准入关卡已被清除。该公司预计将在2026年9月迎来首批收入。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBL.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141091983","title":"Control Bionics 完成Neurostrip美国FDA注册与设备列名","url":"https://stock-news.laohu8.com/highlight/detail?id=1141091983","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141091983?lang=zh_cn&edition=fundamental","pubTime":"2026-08-04 06:42","pubTimestamp":1785796948,"startTime":"0","endTime":"0","summary":"Control Bionics Ltd 近日宣布，已成功完成其Neurostrip产品在美国食品药品监督管理局的注册以及设备列名程序。从注册到列名，整个过程严格遵循了美国监管机构的标准，体现出Control Bionics对品质与安全的极高要求。对于投资者而言，这一进展无疑为Control Bionics的价值增长注入了新的动力。市场普遍预期，随着FDA的官方认可，Neurostrip将有望在更广泛的临床场景中得到应用，进而推动公司营收与品牌影响力的双重提升。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","CBL.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CBL.AU\",params:#limit:6,delay:true,,,undefined,":[]}}